| Literature DB >> 26768771 |
Albert W Cheng1,2,3, Nathaniel Jillette1,2, Phoebe Lee1, Dylan Plaskon1, Yasuhiro Fujiwara1, Wenbo Wang1, Aziz Taghbalout2, Haoyi Wang1,4.
Abstract
Entities:
Mesh:
Substances:
Year: 2016 PMID: 26768771 PMCID: PMC4746610 DOI: 10.1038/cr.2016.3
Source DB: PubMed Journal: Cell Res ISSN: 1001-0602 Impact factor: 25.617
Figure 1The Casilio system enables multiplexing and multimerization of effectors for gene regulation, epigenetic editing and chromosomal labeling. (A) Schematics of the Casilio system. Top: comparison of conventional dCas9 fusion and Casilio tethering of effectors. Center: the 8-repeat PUF domain and the corresponding 8-mer target RNA. Table shows PUF diresidues and the corresponding RNA base. Bottom: annotation for the 4 PUF isotypes and PBS used in this study. (B) The specificity of the Casilio system. Column plot shows mean fold changes (mean ± SEM; n = 3) of tdTomato fluorescence of cells transfected with the indicated constructs. (C) Multimerization of activators by the Casilio system enables robust activation of endogenous OCT4 gene. Upper: schematic showing positions of 4 sgRNA-PBS used to activate OCT4. Lower: mean fold changes (mean ± SEM; n = 3) measured by qRT-PCR of OCT4 expression induced by dCas9/PUFa-p65HSF1 or dCas9-p65HSF1 activator with the indicated cocktail of OCT4 or control sgRNAs-5×PBSa. (D) The Casilio system can activate and repress different genes simultaneously. Column plots show mean fold changes of OCT4 (upper) and SOX2 gene expression (lower) in cells transfected with the indicated constructs. (E) Recruitment of the HAT domain by the Casilio system to enhancers to activate OCT4 expression. HEK293T cells were overexpressed with different HAT fusions and cocktails of 4 sgRNA-5×PBSa targeting PP, PE or DE as indicated. qRT-PCR was performed to evaluate the fold changes of OCT4 expression. (F) Simultaneous labeling of telomeres and centromeres by the Casilio system (scale bars: 5 μm). (i) Labeling of telomeres by Clover-PUFa and sgTelomere with 0, 5, 15 or 25 copies of PBSa. (ii) TRF2 immunostaining to validate labeling of telomeres by dCas9/Clover-PUFa/sgTelomere-25×PBSa. (iii) CREST immunostaining to validate labeling of centromeres by dCas9/Clover-PUFc/sgCentromere-20×PBSc. (iv) Co-labeling of centromeres and telomeres by the Casilio system. (G) Cartoon highlighting three major features of the Casilio system.